Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5M+12.5% YoY

Gross Profit

$4M71.5% margin

Operating Income

-$4M-73.7% margin

Net Income

-$4M-73.6% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-1.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$58M

Total Liabilities

$18M

Stockholders' Equity

$40M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$5M	+12.5%
Gross Profit	$4M	$3M	+21.0%
Operating Income	-$4M	-$4M	+0.2%
Net Income	-$4M	-$4M	+4.8%

Revenue Segments

Functional Neurosurgery Navigation and Therapy

$2M24%

Biologics And Drug Delivery

$2M22%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M20%

Biologics And Drug Delivery - Services

$1M14%

Biologics And Drug Delivery - Disposable Products

$798,0008%

Capital Equipment And Software

$480,0005%

Functional Neurosurgery Navigation and Therapy - Services

$375,0004%

Capital Equipment And Software - Systems and Software Products

$287,0003%

Capital Equipment And Software - Services

$193,0002%